Sagimet Biosciences (SGMT) Other Accumulated Expenses (2022 - 2026)

Sagimet Biosciences' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $15000.0 for Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 6.25% year-over-year to $15000.0; the TTM figure through Mar 2026 stood at $15000.0 (down 6.25% YoY), while the FY2025 annual figure was $27000.0, up 440.0% from the prior year.
• Other Accumulated Expenses was $15000.0 for Q1 2026 at Sagimet Biosciences, down from $27000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $233000.0 in Q4 2023 to a low of $1000.0 in Q2 2025.
• Historically, Other Accumulated Expenses has averaged $48416.7 across 5 years, with a median of $15500.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses sank 97.85% in 2024, then jumped 440.0% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $57000.0 in 2022, then surged by 308.77% to $233000.0 in 2023, then tumbled by 97.85% to $5000.0 in 2024, then surged by 440.0% to $27000.0 in 2025, then slumped by 44.44% to $15000.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $15000.0 (Q1 2026), $27000.0 (Q4 2025), and $8000.0 (Q3 2025), per Business Quant data.